141 related articles for article (PubMed ID: 38096467)
1. Developing the POTOMAC Model: A Novel Prediction Model to Study the Impact of Lymphopenia Kinetics on Survival Outcomes in Head and Neck Cancer Via an Ensemble Tree-Based Machine Learning Approach.
Kut C; Midthune D; Lee E; Fair P; Cheunkarndee T; McNutt T; DeWeese T; Fakhry C; Kipnis V; Quon H
JCO Clin Cancer Inform; 2023 Sep; 7():e2300058. PubMed ID: 38096467
[TBL] [Abstract][Full Text] [Related]
2. Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.
Campian JL; Sarai G; Ye X; Marur S; Grossman SA
Head Neck; 2014 Dec; 36(12):1747-53. PubMed ID: 24174270
[TBL] [Abstract][Full Text] [Related]
3. Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers.
Lin AJ; Rao YJ; Chin RI; Campian J; Mullen D; Thotala D; Daly M; Gay H; Oppelt P; Hallahan D; Adkins D; Thorstad W
Oral Oncol; 2018 Nov; 86():1-7. PubMed ID: 30409288
[TBL] [Abstract][Full Text] [Related]
4. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.
Lin AJ; Gang M; Rao YJ; Campian J; Daly M; Gay H; Oppelt P; Jackson RS; Rich J; Paniello R; Zevallos J; Hallahan D; Adkins D; Thorstad W
JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):413-421. PubMed ID: 30920592
[TBL] [Abstract][Full Text] [Related]
5. Prognostic model for overall survival of head and neck cancer patients in the palliative phase.
Hoesseini A; Sewnaik A; van den Besselaar BN; Zhang J; van Leeuwen N; Hardillo JA; Baatenburg de Jong RJ; Offerman MPJ
BMC Palliat Care; 2024 Feb; 23(1):54. PubMed ID: 38395897
[TBL] [Abstract][Full Text] [Related]
6. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.
Cho O; Oh YT; Chun M; Noh OK; Lee HW
Tumour Biol; 2016 Jan; 37(1):971-8. PubMed ID: 26264618
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
Rühle A; Stromberger C; Haehl E; Senger C; David H; Stoian R; Zamboglou C; Knopf A; Budach V; Grosu AL; Nicolay NH
Radiother Oncol; 2021 Jan; 154():276-282. PubMed ID: 33245947
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram.
van Rossum PSN; Deng W; Routman DM; Liu AY; Xu C; Shiraishi Y; Peters M; Merrell KW; Hallemeier CL; Mohan R; Lin SH
Pract Radiat Oncol; 2020; 10(1):e16-e26. PubMed ID: 31369887
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
12. Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancers.
Césaire M; Rambeau A; Cherifi F; Géry B; Johnson A; Nacher M; Thariat J
Cancer Radiother; 2023 Apr; 27(2):145-153. PubMed ID: 36759240
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
14. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
15. Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I).
Bernatz S; Böth I; Ackermann J; Burck I; Mahmoudi S; Lenga L; Martin SS; Scholtz JE; Koch V; Grünewald LD; Koch I; Stöver T; Wild PJ; Winkelmann R; Vogl TJ; Dos Santos DP
BMC Med Imaging; 2023 Jun; 23(1):71. PubMed ID: 37268876
[TBL] [Abstract][Full Text] [Related]
16. Utility of palliative prognostic index and neutrophil-to-lymphocyte ratio in predicting prognosis of end-stage squamous cell carcinoma of head and neck.
Higashino M; Sugimoto K; Onishi S; Okabe K; Yasuda C; Tadokoro H; Kawata R
Head Neck; 2024 Jan; 46(1):23-28. PubMed ID: 37850401
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Patel DA; Xi J; Luo J; Hassan B; Thomas S; Ma CX; Campian JL
Breast Cancer Res Treat; 2019 Apr; 174(2):443-452. PubMed ID: 30604000
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma.
De B; Ludmir EB; Messick CA; Cagley MC; Morris VK; Das P; Minsky BD; Taniguchi CM; Smith GL; Koay EJ; Koong AC; Mohan R; Holliday EB
J Gastrointest Oncol; 2021 Oct; 12(5):2412-2422. PubMed ID: 34790402
[TBL] [Abstract][Full Text] [Related]
20. Impact of lymphopenia on efficacy of nivolumab in head and neck cancer patients.
Césaire M; Rambeau A; Clatot F; Johnson A; Heutte N; Thariat J
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2453-2461. PubMed ID: 36564669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
